CEBPA and myeloid leukemia: Our finding of decreased expression of C/EBPα in SCC concurs with previous reports implicating C/EBPα as a tumor suppressor in myeloid leukemia [8] and cutaneous SCC [14], is consistent with suggestions that low C/EBPα expression in tumors contributes to failure of cell cycle arrest [7], [9], [10], [12], [33].